Tetrasialotransferrin

Tetrasialotransferrin is the predominant glycoform of transferrin, the protein that carries iron in your blood. The test measures the proportion of transferrin molecules that have a typical pattern of sugar attachments, reported as a percentage of all transferrin forms present.

Laboratories separate transferrin isoforms using methods such as capillary electrophoresis, isoelectric focusing, or mass spectrometry to assess protein glycosylation. Because glycosylation reflects how your cells build and attach sugar chains to proteins, this measurement helps evaluate that cellular process.

This test is most often used to screen for and monitor congenital disorders of glycosylation, a group of inherited conditions that alter the pattern of transferrin glycoforms. Changes in this marker can also be seen with significant liver disease, heavy alcohol use, or rare inherited variants of transferrin, so it provides important context when these conditions are being considered.

Your clinician may order the test if there are concerns about a glycosylation disorder, unexplained developmental or neurologic findings, unexplained liver abnormalities, or to clarify results from a carbohydrate deficient transferrin panel. It can also help track trends over time alongside clinical findings and other laboratory studies.

Your result reflects the percentage of tetrasialotransferrin relative to all transferrin isoforms. A lower-than-expected percentage often occurs when other isoforms are increased and can suggest a pattern seen in certain glycosylation disorders. Similar patterns can be produced by advanced liver disease, substantial alcohol use, or inherited transferrin variants, so results are interpreted in the context of your history, examination, and other laboratory tests.

If your value falls outside the expected range, your clinician may repeat the test, request a complete transferrin isoform profile, order liver function testing, or pursue confirmatory studies such as genetic testing or enzyme analysis. A result within the expected range does not exclude all glycosylation disorders, and further evaluation may still be appropriate based on your symptoms and medical history.